Catalyst Health Economics Consultants

Hormone Replacement Therapy

1. Cost of managing postmenopausal women with climacteric symptoms receiving Livial™and Kliofem™ in the UK.

Presented at the 10th Anniversary Meeting of the British Menopause Society, Manchester, June 1999 and the 9th International Menopause Society World Congress on the Menopause, Yokohama, October 1999. Climacteric 1999; 2(Suppl 1): 324.

2. The economic impact of tibolone compared to continuous-combined HRT in the management of postmenopausal women with climacteric symptoms in the UK.

Authors: JM Plumb & JF Guest.
Source: PharmacoEconomics 2000; 18(5): 477-486.

View Abstract

3. Economic impact of tibolone versus continuous-combined HRT.

Authors: JM Plumb & JF Guest.
Source: Menopause Digest 2001; 13(3): 14-16.


<<< Go Back

Catalyst Health Economics Consultants Ltd
© 1991 - 2018